Vous êtes sur la page 1sur 2

NURSING PHARMACOLOGY SHEET

Name of Patient: H. ALTARES


Age & Sex: 73 yrs old/ Female
Principal Diagnosis: HPN Urgency, Chronic CVD Infarct
Allergy: None
C/c: Dyspnea and Decrease I & O
Drug Name
Indication/ Contraindication Mechanism of Action Side Effects/ Adverse Effect Nursing Considerations

Generic Name: Indications: Atorvastatin competitively Adverse Effect: Stress that atorvastatin is an
Atorvastatin Reduction of risk of inhibits HMG-CoA reductase, Headache, flatulence, diarrhoea, adjunct to not a substitute
stroke and heart attack in type the enzyme that catalyses the nausea, vomiting, anorexia, for low-cholesterol diet
Brand Name: 2 diabetes patients without conversion of HMG-CoA to xerostomia, angioedema, Tell patient to take drug at the
lipitor evidence of heart disease but mevalonic acid. This results in myalgia, rash/pruritus, alopecia, same time each day to
with other CV risk factors, and the induction of the LDL allergy, infection, chest pain. maintain its effects
Classification: revascularization procedures in receptors, leading to lowered Instruct patient to take a
Dyslipidaemic Agent patients without evidence of LDL-cholesterol concentration. Potentially missed dose as soon as
coronary heart disease (CHD) Absorption: Rapid from the GI Fatal: Thrombocytopenia. possible. If its almost time
Dosage: but with multiple risk factors tract (oral). Rhabdomyolysis with acute for his next dose, he should
20mg other than diabetes (eg, Distribution: Protein-binding: renal failure. skip the missed dose.
smoking, HTN, low HDL-C, 98%.
Advise patient to notify
Frequency: family history of early CHD) Metabolism: Extensively
prescriber immediately if he
Once daily 2000H Patients with CHD, to hepatic; converted to active
develops unexplained muscle
reduce risks of MI, inhibitors of HMG-CoA
pain, tenderness, or weakness,
Route: revascularization procedures, reductase.
especially if accompanied by
G-tube hospitalization for CHF, and Excretion: Faeces (as
fatigue or fever
angina metabolites); 14 hr (elimination
Date ordered: half-life).
March 19, 2014 Contraindication:
Hypersensitivity, active liver
disease or unexplained persistent
elevations of serum
transaminase, porphyria,
pregnancy, lactation.

Vous aimerez peut-être aussi